Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study

被引:2525
作者
Vincent, JL
de Mendonca, A
Cantraine, F
Moreno, R
Takala, J
Suter, PM
Sprung, CL
Colardyn, F
Blecher, S
机构
[1] Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium
[2] Univ Hosp, Ghent, Belgium
[3] Kuopio Univ Hosp, SF-70210 Kuopio, Finland
[4] Hebrew Univ Jerusalem, Hadassah Med Ctr, Jerusalem, Israel
[5] Hosp Santo Antonio dos Capuchos, Lisbon, Portugal
[6] Casa Saude Santa Marcelina, Sao Paulo, Brazil
关键词
outcome; morbidity; organ failure; critically ill; intensive care; respiratory failure; renal failure; hepatic failure; coagulation abnormalities; neurologic dysfunction; circulatory shock; circulatory failure;
D O I
10.1097/00003246-199811000-00016
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To evaluate the use of the Sequential Organ Failure Assessment (SOFA) score in assessing the incidence and severity of organ dysfunction in critically ill patients. Design: Prospective, multicenter study. Setting: Forty intensive care units (ICUs) in 16 countries. Patients: Patients admitted to the ICU in May 1995 (n = 1,449), excluding patients who underwent uncomplicated elective surgery with an ICU length of stay <48 hrs. Interventions: None. Measurements and Main Results: The main outcome measures included incidence of dysfunction/failure of different organs and the relationship of this dysfunction with outcome. In this cohort of patients, the median length of ICU stay was 5 days, and the ICU mortality rate was 22%. Multiple organ dysfunction and high SOFA scores for any individual organ were associated with increased mortality. The presence of infection on admission (28.7% of patients) was associated with higher SOFA scores for each organ. The evaluation of a subgroup of 544 patients who stayed in the ICU for at least 1 wk showed that survivors and nonsurvivors followed a different course. This subgroup had greater respiratory, cardiovascular, and neurologic scores than the other patients. In this subgroup, the total SOFA score increased in 44% of the nonsurvivors but in only 20% of the survivors (p < .001). conversely, the total SOFA score decreased in 33% of the survivors compared with 21% of the nonsurvivors (p < .001). Conclusions: The SOFA score is a simple, but effective method to describe organ dysfunction/failure in critically ill patients. Regular, repeated scoring enables patient condition and disease development to be monitored and better understood. The SOFA score may enable comparison between patients that would benefit clinical trials.
引用
收藏
页码:1793 / 1800
页数:8
相关论文
共 24 条
  • [1] REPORT OF THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ACUTE RESPIRATORY-DISTRESS SYNDROME - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION
    BERNARD, GR
    ARTIGAS, A
    BRIGHAM, KL
    CARLET, J
    FALKE, K
    HUDSON, L
    LAMY, M
    LEGALL, JR
    MORRIS, A
    SPRAGG, R
    Cochin, B
    Lanken, PN
    Leeper, KV
    Marini, J
    Murray, JF
    Oppenheimer, L
    Pesenti, A
    Reid, L
    Rinaldo, J
    Villar, J
    van Asbeck, BS
    Dhainaut, JF
    Mancebo, J
    Matthay, M
    Meyrick, B
    Payen, D
    Perret, C
    Fowler, AA
    Schaller, MD
    Hudson, LD
    Hyers, T
    Knaus, W
    Matthay, R
    Pinsky, M
    Bone, RC
    Bosken, C
    Johanson, WG
    Lewandowski, K
    Repine, J
    Rodriguez-Roisin, R
    Roussos, C
    Antonelli, MA
    Beloucif, S
    Bihari, D
    Burchardi, H
    LeMaire, F
    Montravers, P
    Petty, TL
    Robotham, J
    Zapol, W
    [J]. JOURNAL OF CRITICAL CARE, 1994, 9 (01) : 72 - 81
  • [2] BERNARD GR, 1995, AM J RESP CRIT CARE, V151, pA323
  • [3] PREDICTING OUTCOME AMONG INTENSIVE-CARE UNIT PATIENTS USING COMPUTERIZED TREND ANALYSIS OF DAILY APACHE-II SCORES CORRECTED FOR ORGAN SYSTEM FAILURE
    CHANG, RWS
    JACOBS, S
    LEE, B
    [J]. INTENSIVE CARE MEDICINE, 1988, 14 (05) : 558 - 566
  • [4] INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
    Cohen, J
    Carlet, J
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (09) : 1431 - 1440
  • [5] PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER CLINICAL-TRIAL
    DHAINAUT, JFA
    TENAILLON, A
    LETULZO, Y
    SCHLEMMER, B
    SOLET, JP
    WOLFF, M
    HOLZAPFEL, L
    ZENI, F
    DREYFUSS, D
    MIRA, JP
    DEVATHAIRE, F
    GUINOT, P
    [J]. CRITICAL CARE MEDICINE, 1994, 22 (11) : 1720 - 1728
  • [6] The spectrum of septic encephalopathy - Definitions, etiologies, and mortalities
    Eidelman, LA
    Putterman, D
    Putterman, C
    Sprung, CL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (06): : 470 - 473
  • [7] Risk factors for postoperative morbidity
    Ferraris, VA
    Ferraris, SP
    Edmunds, LH
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (04) : 731 - 741
  • [8] Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein
    Fisher, CJ
    Agosti, JM
    Opal, SM
    Lowry, SF
    Balk, RA
    Sadoff, JC
    Abraham, E
    Schein, RMH
    Benjamin, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) : 1697 - 1702
  • [9] RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    FISHER, CJ
    DHAINAUT, JFA
    OPAL, SM
    PRIBBLE, JP
    BALK, RA
    SLOTMAN, GJ
    IBERTI, TJ
    RACKOW, EC
    SHAPIRO, MJ
    GREENMAN, RL
    REINES, HD
    SHELLY, MP
    THOMPSON, BW
    LABRECQUE, JF
    CATALANO, MA
    KNAUS, WA
    SADOFF, JC
    ASTIZ, M
    CARPATI, C
    BONE, RC
    FREIDMAN, B
    MURE, AJ
    BRATHWAITE, C
    SHAPIRO, E
    MELHORN, L
    TAYLOR, R
    KEEGAN, M
    OBRIEN, J
    SCHEIN, R
    PENA, M
    WASSERLOUF, M
    OROPELLO, J
    BENJAMIN, E
    DELGUIDICE, R
    EMMANUEL, G
    LIE, T
    ANDERSON, L
    MARSHALL, J
    DEMAJO, W
    ROTSTEIN, O
    FOSTER, D
    ABRAHAM, E
    MIDDLETON, H
    PERRY, C
    LEVY, H
    FRY, DE
    SIMPSON, SQ
    CROWELL, RE
    NEIDHART, M
    STEVENS, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23): : 1836 - 1843
  • [10] APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM
    KNAUS, WA
    DRAPER, EA
    WAGNER, DP
    ZIMMERMAN, JE
    [J]. CRITICAL CARE MEDICINE, 1985, 13 (10) : 818 - 829